Yüklüyor......
Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy
Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID‐19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS‐A/D). 30% of patients displayed pathological HADS‐A/D, 52.4% showed persistent symptoms. Pathological pa...
Kaydedildi:
| Yayımlandı: | J Med Virol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7461061/ https://ncbi.nlm.nih.gov/pubmed/32841387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26459 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|